USTEKINUMAB TROUGH LEVELS ARE ASSOCIATED WITH SONOGRAPHIC TRANSMURAL HEALING IN PEDIATRIC INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Kellar, Amelia
Aronskyy, Illya
Dubinsky, Marla C.
Dolinger, Michael T.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1996
引用
收藏
页码：S1180 / S1180
页数：1
相关论文
共 50 条
  • [31] CLINICAL EXPERIENCE WITH VEDOLIZUMAB TROUGH LEVELS IN INFLAMMATORY BOWEL DISEASE
    Al-Bawardy, Badr
    Ramos, Guilherme Piovezani
    Willrich, Maria Alice V.
    Park, Sang Hyoung
    Aniwan, Satimai
    Raffals, Laura H.
    Tremaine, William J.
    Loftus, Edward V.
    GASTROENTEROLOGY, 2018, 154 (06) : S821 - S822
  • [32] VEDOLIZUMAB TROUGH LEVELS AND CLINICAL OUTCOMES IN INFLAMMATORY BOWEL DISEASE
    Guidi, L.
    Pugliese, D.
    Tonucci, T. Panici
    Tolusso, B.
    Felice, C.
    Papa, A.
    Ennas, S.
    Di Mario, C.
    Gasbarrini, A.
    Rapaccini, G. L.
    Armuzzi, A.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E99 - E100
  • [33] Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease
    Choi, So Yoon
    Kang, Ben
    Lee, Jee Hyun
    Choe, Yon Ho
    GUT AND LIVER, 2017, 11 (01) : 55 - 61
  • [34] Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease
    Sekhri, Shaina
    Rao, Bharat
    Mohananey, Akanksha
    Beniwal-Patel, Poonam
    Bruss, Alexandra
    Stein, Daniel J.
    Yarur, Andres J.
    BMJ OPEN GASTROENTEROLOGY, 2021, 8 (01):
  • [35] Which are the optimal adalimumab trough levels associated with biological remission in patients with inflammatory bowel disease?
    Serra, K.
    Rodriguez-Alonso, L.
    Padulles, N.
    Rodriguez-Moranta, F.
    Arajol, C.
    Gilabert, P.
    Rodriguez, R.
    Bas, J.
    Morandeira-Rego, F.
    Santacana, E.
    Padulles, A.
    Guardiola, J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S358 - S358
  • [36] Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease
    van Hoeve, Karen
    Dreesen, Erwin
    Hoffman, Ilse
    Van Assche, Gert
    Ferrante, Marc
    Gils, Ann
    Vermeire, Severine
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (11): : 1316 - 1325
  • [37] SERUM INFLIXIMAB TROUGH LEVELS ARE NOT ASSOCIATED WITH ACTIVE PERIPHERAL ARTHRALGIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Sekhri, Shaina
    Rao, Bharat
    Mohananey, Akanksha
    Beniwal-Patel, Poonam
    Stein, Daniel J.
    Yarur, Andres J.
    GASTROENTEROLOGY, 2021, 160 (06) : S693 - S694
  • [38] Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study
    Yacoub, W.
    Williet, N.
    Pouillon, L.
    Di-Bernado, T.
    Bittencourt, M. De Carvalho
    Nancey, S.
    Lopez, A.
    Paul, S.
    Zallot, C.
    Roblin, X.
    Peyrin-Biroulet, L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (07) : 906 - 912
  • [39] Ustekinumab Use in Pediatric Inflammatory Bowel Disease: A French Multicenter Study From the Pediatric GETAID
    Koudsi, Mounzer
    Martinez-Vinson, Christine
    Pigneur, Benedicte
    Willot, Stephanie
    Djamal, Djeddi
    Enaud, Raphael
    Rebeuh, Julie
    Dupont, Claire
    Dabadie, Alain
    Bertrand, Valerie
    Hugot, Jean-Pierre
    Lachaux, Alain
    Ruemmele, Franck
    Viala, Jerome
    Duclaux-Loras, Remi
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 76 (06): : 763 - 770
  • [40] Vedolizumab Trough Levels in Inflammatory Bowel Disease: Initial Clinical Experience
    Badr, Al-Bawardy
    Guilherme, Piovezani Ramos
    Loftus, Edward, Jr.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S26 - S26
12345